TRANSCRIPT

Q4 2020 — Fixed income call transcript

Q4 2020PDF · 15 pages127 KB
Deutsche Bank AG
Deutsche Bank Q4 2020 Fixed Income Conference Call
Friday, 5 February 2021 | 15:00 CET
Transcript
Speakers
James von Moltke, Chief Financial Officer
Dixit Joshi, Group Treasurer
Philip Teuchner, Investor Relations

-- 1 of 15 --

2
Philip Teuchner 	Thank you, Hayley. Good afternoon or good morning and thank
you all for joining us today. On the call, as always, our CFO,
James von Moltke, will speak first. Then, our Group Treasurer,
Dixit Joshi, will take us through some Fixed Income-specific
topics. For Q&A, we also have Jonathan Blake, our Global Head
of Issuance & Securitisation, and Ralf Leiber, Head of Group
Capital Management, with us.
The slides that accompany the topics are available for download
from our website, at db.com. After the presentation, we’ll be
happy to take your questions but, before we get started, I just
want to remind you that the presentation may contain forward-
looking statements which may not develop as we currently
expect. Therefore, please take note of the precautionary
warning at the end of our materials. With that, let me hand over
to James.
James von Moltke 	Thank you, Philip, and welcome from me. Our performance in
the fourth quarter and in the full year shows the progress we
have made in executing on our strategy. We were profitable on
a pre and post-tax basis in the fourth quarter, and the full year
on a Group level. The improved profitability in the Core Bank
offset the continuing transformation effects, higher provisions
for credit losses, and continued de-risking in the Capital
Release Unit.
We have demonstrated execution discipline as we hit all of our
key targets and milestones in 2020 and over the last 18 months,
despite the challenges of COVID-19. Our diversified loan book
and disciplined risk framework help us to manoeuvre during
uncertain times. We remain disciplined on capital while we grow
our businesses. By now, we have put aside any doubts that we
can self-fund our transformation.
Let 	us 	look 	at 	a 	summary 	of 	our 	financial 	performance
compared to the prior year, on slide four. Operating leverage
was strong in the fourth quarter at 23% on a reported basis, as
revenues increased by 2% and non-interest expenses declined
by 21%.
Adjusting 	for 	specific 	revenue 	and cost 	items, 	operating
leverage was 12%. On this basis, we grew revenues by 4% and
reduced costs by 8%. We generated a profit before tax of € 175
million or € 621 million excluding transformation charges,
restructuring and severance, and specific revenue items. For
the full year, we generated a pre-tax profit of € 1.0 billion.
Provisions for credit losses was € 1.8 billion in the full year, in
line with our expectations at 41 basis points of average loans.
Our improved results are supported by growing revenues under
our refocused business model, as you can see on slide five.

-- 2 of 15 --

3
We’ve increased Group revenues by € 800 million in 2020, as
growth in our core businesses more than offset the exit from
equities trading. Core Bank revenues have increased by 6% to
€ 24.2 billion. This puts us close to the plan of € 24.4 billion that
we laid out at the investor deep dive as part of our path to the
8% return on tangible equity target in 2022.
This 	growth 	has 	principally 	come 	from 	our 	refocused
Investment Bank, which was able to capitalise on favourable
market conditions and to deliver on the strategic transformation
of our fixed income business.
The Corporate Bank and Private Bank successfully offset
headwinds, primarily lower interest rates, to keep revenues
essentially 	stable 	year-on-year, 	and 	we 	would 	expect
underlying growth to feed through to the top line as interest rate
headwinds soften, consistent with the forward curve. Asset
Management was slightly lower, due to the non-recurrence of
certain 	performance 	fees 	in 	2020. 	In 	summary, 	all 	our
businesses executed on their strategic objectives.
Slide six shows the progress we have made in reducing
adjusted costs. Excluding transformation charges and bank
levies, we’ve reduced adjusted costs year-on-year for 12
consecutive quarters. In 2020, we reduced adjusted costs,
excluding transformation charges and expenses eligible for
reimbursement related to Prime Finance, by 9%.
On this basis, and excluding bank levies, our fourth quarter run
rate puts on a good path to our 2022 target of € 16.7 billion. This
run rate also leaves room for targeted investments in 2021, as
we highlighted to you in December.
Let us now move to slide seven to discuss our provisions for
credit losses. Consistent with our prior guidance, provisions for
credit losses remained at more normalised levels in the fourth
quarter. Provisions were € 251 million in the quarter, equivalent
to 23 basis points of loans on an annualised basis. The decline
for the fourth quarter is driven by releases in COVID-19-related
Stage 1 and 2 provisions, reflecting positive changes in
consensus macroeconomic outlook since the third quarter.
Stage 3 provisions declined by 14% in the quarter but remain
more elevated in the Private Bank and the Investment Bank. We
retained the management overlay we established in the third
quarter, given continued uncertainties in the macroeconomic
outlook.
Including the provisions taken in the fourth quarter, we ended
the period with an allowance for loan losses of € 4.8 billion,
equivalent to 111 basis points of loans. Our plans assume

-- 3 of 15 --

4
provisions for credit losses will decline this year compared to
2020 but will remain elevated compared to pre-COVID-19
levels.
Our disciplined execution is increasingly visible in our results, as
you can see on slide eight. The next phase of our transformation
is to further improve sustainable profitability by growing
revenues 	and, 	at 	the 	same 	time, 	reducing 	costs. 	We’ve
generated positive double-digit operating leverage in 2020 at
both Group and Core Bank levels. The operating leverage has
driven significant improvements in Core Bank profitability.
Adjusted for transformation charges, specific revenue items,
goodwill impairments, as well as restructuring and severance,
pre-tax profit in the Core Bank is up 52% in 2020 to € 4.2 billion.
Over time, more of the Core Bank’s profitability should flow to
the Group’s bottom line as we continue to make progress on our
transformation 	agenda 	and 	provisions 	for 	credit 	losses
normalise.
The strength of our balance sheet at year end, which we discuss
on slide nine, also positions us well to further grow our
businesses. Our Common Equity Tier 1 ratio was at 13.6%,
essentially flat year-on-year. Liquidity reserves and liquidity
coverage ratio were both above prior year levels. Dixit will go
into more detail later. As a result, we can deploy our capital and
liquidity strength to support clients in what is still and uncertain
environment.
Finally, as we explained, both in December and at our Risk Deep
Dive in June last year, we have benefitted from a high-quality
loan book and a disciplined credit risk framework that enable us
to deliver within our guidance on provisions for credit losses.
Our transformation is fully on track and our performance in
2020 gives us good visibility towards our 2022 targets. With
that, let me hand over to Dixit.
Dixit Joshi 	Thank you James. Let me start with a summary of the progress
we made in 2020, which positions us well for 2021, on slide 11.
We continue to optimise our balance sheet, including the rollout
of deposit charging. On capital, we have increased the buffer
above our regulatory capital requirements to € 10 billion,
reflecting the Tier 2 issuance earlier this month.
We are pleased with the way capital markets are reacting to our
transformation. Our spreads have tightened significantly in
2020, 	outperforming 	peers. 	For 	example, 	or 	senior 	non-
preferred debt tightened year-on-year by roughly 40 basis
compared to 2019 and has outperformed peers by around 30
basis 	points, 	on 	average, 	across 	our 	main 	refinancing
currencies, euros and US dollars. This positive development

-- 4 of 15 --

5
and the flexibility of our balance sheet allowed us to pre-fund
around € 5.0 billion of our 2021 requirements.
In addition, we saw positive actions from ratings agencies. This
includes the recent outlook revisions from Fitch and Moody’s to
positive and stable, respectively. Overall, these developments
support our commitment to deliver sustainable profitability,
while we continue to invest in our technology, including our
modelling, our infrastructure and our controls.
Slide 12 shows a summary of the net balance sheet which
excludes pending netting agreements, cash collateral, as well
as pending settlements. Liquidity reserves continue to account
for about a quarter of the net balance sheet.
Our loan-to-deposit ratio, at 76%, provides significant room to
prudently grow loan balances in coming periods and our
funding 	profile 	remains 	well-diversified. 	The 	most 	stable
funding sources were 82% of our net balance sheet or 87%
including TLTRO. Low cost deposits are our main funding
source, contributing almost 60%, and we have steadily reduced
our reliance on unsecured wholesale funding, which is now less
than 1% of net liabilities.
Moving to liquidity on slide 13, you can see that we made
progress in managing down excess liquidity over the quarter.
This is primarily driven by a reduction in Corporate Bank
deposits, 	reflecting 	our 	targeted 	initiatives 	to 	proactively
manage liabilities, partially offset by a modest increase in
Private Bank deposits.
Loans remained flat in the quarter but, excluding FX effects, we
saw ongoing loan growth, primarily in the Private Bank. Overall,
we ended the year with liquidity reserves of € 243 billion and a
liquidity coverage ratio of 145%. On a year-on-year basis,
liquidity reserves increased € 21 billion, predominantly driven
by model enhancements and low-cost TLTRO funding, which
we will discuss on the next slide.
As we execute on our transformation, continued improvements
to our technology and models can drive changes to our liquidity
metrics. In 2020, those changes resulted in increases in liquidity
with no incremental associated costs. Model enhancements, of
course, can also reduce liquidity, and our liquidity levels allow
us to navigate comfortably any external or internal changes.
Over time, we intend to prudently manage our liquidity towards
targeted levels.
Slide 14 provides further context of the lower cost and the
improved quality of our funding sources. Funding costs are, and
will remain, attractive for longer, following the ECB’s updates

-- 5 of 15 --

6
TLTRO-III terms. In 2020, we accrued at a funding rate in line
with the ECB’s deposit rate facility, having achieved sufficient
certainty of meeting the growth required in the March 2019 to
March 2021 observation window.
As we accrued in the third quarter at a more conservative rate,
accounting for the uncertainty of fully achieving the loan growth
requirement, we have reflected an additional € 45 million in
revenues 	in 	the 	fourth 	quarter 	related 	to 	meeting 	this
requirement. 	Subject 	to 	our 	achievement 	of 	the 	ECB’s
additional loan growth target, we would expect a further 50
basis points reduction in the cost of the facility for the period
from June 20-21. This would result in additional revenues of
around € 120 million in the first quarter, reflecting the catch-up
of our conservative accounting in 2020.
In addition, we continued making progress improving the
composition of our deposit base. We actively worked to reduce
unsecured wholesale funding and non-operating Corporate
Bank deposits while growing more stable retail deposits. All of
these initiatives have resulted in continuing lower cost of
funding.
Turning to capital on slide 15. Our CET1 ratio was 13.6% at the
end of 2020, above the guidance of 13% that we provided at the
investor deep dive. Approximately 20 basis points came from
lower risk-weighted assets, notably faster than anticipated
reductions in the Capital Release Unit and slightly lower
deployment in the Core Bank.
A further 20 basis points of the outperformance came from a
series of numerator benefits, including higher than expected
net income and higher than expected benefits from regulatory
changes relating to software, intangibles and other items.
The balance of 20 basis points came from delays in regulatory
inflation, principally the targeted review of internal models,
which we expected to conclude in the fourth quarter. € 4 billion
of RWA inflation related to TRIM is now expected to occur in
the first quarter of 2021, which increases our full year regulatory
inflation assumption to approximately €20 billion.
Nearly, all of this RWA inflation is expect to occur in the first half
of 2021, equivalent to approximately 80 basis point of CET1
capital. This takes our pro forma CET1 ratio to approximately
12.8%. With this inflation behind us in the first half of the year,
we expect to see much more moderate impact from regulatory
items in the second half of ’21 and for the full year 2022.
As shown on slide 16, we ended 2020 with a 13.6% CET1 ratio,
316 basis points buffer over the CET1 requirement, which is an

-- 6 of 15 --

7
increase of 31 basis points versus September. The distance to
the total capital requirement is up 17 basis points on a reported
basis and up 48 basis points on a pro forma basis, including our
January 2021 Tier 2 issuance.
Post our successful Tier 2 issuance, we now have 308 basis
points or € 10 billion of capital headroom over the total capital
requirement. This puts us in a comfortable starting point to
absorb the upcoming RWA inflation that we discussed.
Moving to slide 17, our leverage ratio improved by 24 basis
points to 4.7%, reflecting the positive regulatory-driven and
other capital effects I described before. Our pro forma leverage
ratio, including ECB balances, was 4.3%. This puts us well on
track to meet our leverage ratio target of 4.5% by year-end
2022, including a further ten basis points from finalising the
transfer of our Prime Finance business later this year.
We continue to operate with a significant loss absorbing
capacity well-above our requirements, as shown on slide 18. At
the end of the fourth quarter, our loss-absorbing capacity was
€ 21 billion above the minimum requirement for eligible
liabilities or MREL, our most binding constraint.
In 	preparation 	for 	the 	long-known 	regulatory 	changes
applicable in 2021, we have held material buffers for some time
now. These changes include a reduction of our MREL capacity
as a result of Brexit, a higher MREL requirement expected to be
set by the SRB in the first half of 2021, and the impact from
regulatory RWA inflation on MREL.
Our MREL headroom will thus normalise to a more reasonable
of approximately € 5.0 billion in the first half of 2021. This is still
well-above our regulatory requirements, which we have always
fully met, without needing a transition period.
Moving now to our issuance plan on slide 19. In 2020 we issued
€ 18.5 billion, compared to our revised plan of € 10-15 billion.
This includes roughly € 5.0 billion of senior non-preferred
issuance in the fourth quarter of 2020 to partially pre-fund our
plans for this, given strong market conditions we saw then.
We also raised a further € 3.5 billion of funding from the ECB’s
TLTRO-III programme in December, offset by the repayment of
€3.0 billion of legacy central bank funding. We expect to use
these funds to optimise the repayment schedule of our central
bank funding while lowering the associated costs.
For 2021, we plan to issue between € 15 to 20 billion in
aggregate compared to maturities of € 22 billion, and we have
already issued roughly € 1.5 billion this year. Roughly, half of

-- 7 of 15 --

8
this requirement is comprised of capital instruments and senior
non-preferred to manage our MDA buffers, as well as MREL
and rating agency requirements.
Our well-balanced maturity profile for 2022 and beyond means
we expect to be able to continue to reduce our capital markets
footprint in future years. This plan assumes that Moody’s
request for comment on the Loss Given Failure methodology
will be implemented as currently drafted.
Before we sum up, let me also say a few words on infection risk.
Infection risk refers to the risk that legacy capital instruments
infect new style capital instruments due to various criteria,
notably ranking and coupon payment conditions. Such infection
can risk new style capital instruments being de-recognised. We
do not see this an issue for our four legacy capital instruments,
as Germany has implemented BRRD II in December of last year,
which legally changes the ranking of these issues to be senior
to new style capital.
In addition, our instruments only contain so-called dividend
pushers which are allowed in this regard. As such, infection risk
is not a factor for us when deciding on whether to call these
instruments. As in the past, therefore, our call decisions will be
rather taken based on economic factors.
In conclusion, on slide 20, our balance sheet remains low risk
and well-funded by highly stable sources. Our solid capital ratio
allows us to navigate through the operating environment which
may remain volatile. The rating agencies have begun to
acknowledge 	our 	transformation 	progress, 	evidenced 	by
outlook provisions from both Moody’s and Fitch. We will
continue to constructively engage with the ratings agencies
throughout 2021.
Our plans assume provisions for credit losses will decline
slightly this year compared to 2020 but will remain elevated
compared to pre-COVID-19 periods. We expect to prudently
manage down our excess liquidity towards our target levels
over time but given the attractive TLTRO conditions we are
under no time pressure to do so. As a result, we feel well-
positioned to work towards our 8% return on tangible equity
target in 2022. With that, let us move on to your questions.
Christy Hajiloizou 	Hello, everyone. Thanks again for the call. I have three, please.
(Barclays) 	The 	first 	is 	on 	the 	MREL 	disclosure. 	Obviously, 	you’re
forecasting, given the increase in MREL requirements and the
reduction in the surplus, that your surplus will now be around €
5 billion. It seems a little bit thin in terms of cushion. Why should
we be comfortable with this given the RWA volatility you might
experience? Then, maybe, just as a follow-up, what would

-- 8 of 15 --

9
actually happen if you did go below the requirement in 2021, if
anything?
The second question is on the Moody’s Loss Given Failure
methodology revisions, which obviously are relevant for your
issuance plans. I’m interested, actually, if you could just remind
me, first of all, what those revisions were and how they would
have affected you? Then, perhaps as a follow-up, what would
actually happen if the Loss Given Failure methodology isn’t
implemented as drafted, if there is any change to your issuance
needs there?
Then, finally, just a quick one on the provisions taken in 2020. I
note that the biggest year-on-year increase came in the
Investment Bank. I was just curious, actually, if you could
comment in just a little bit more detail what sort of sub-
segments within the Investment Bank those provisions related
to. Thank you.
Dixit Joshi 	Christy, hi. This is Dixit, here. I’ll take the first two and James,
the third. On the MREL front, we are comfortable with this low
cushion. We’ve been flagging for some time that these are
known regulatory items and known downside, and that was fully
baked into our issuance plan as well as our balance sheet glide
path for this year and subsequently.
As an example, many of the issuances we have coming up for
maturity this year are already deducted from the MREL
calculation, i.e. appropriately conservative as should be the
case. One is that this is part of the planning and the timelines
were well-known throughout.
When thinking about the surplus, it is important to remember
that we were one of the first banks in Europe to receive a fully-
loaded binding MREL requirement which we’ve exceeded from
the time that we received the binding requirement.
One of the questions that you had was also what happens
should one actually go through the threshold or through the
limit. That would require the SRB to assess any institution-
specific context within an appropriate period of time to be able
to address the issue. So, to that extent, we have the capital
markets that we would seek to tap, so we’re comfortable with
the € 5 billion given we’ve absorbed much of the downside that
we had been expecting now for some time.
On Moody’s LGF, the methodology changes were flagged
through the request for comment last March. The comment
period had complete around May of last year before Moody’s
had 	delayed 	the 	implementation. 	Moody’s 	announced 	in
December that the request for comment will be re-issued in the
second quarter and it’s our expectation that we will see an

-- 9 of 15 --

10
implementation of the new methodology sometime thereafter.
We would hope that by the beginning of the third quarter, that
we would have sufficient clarity around Moody’s LGF. I must
say, though, as you know, we’ve managed through a series of
criteria, including ratings agency criteria, through the last
couple of years and protecting our rating has been important to
us and reflected in our issuance plan, and will remain important
for us going forward.
James von Moltke 	On the provisions for loan losses in the Investment Bank. As
you’d imagine, they arose from what we’ve referred to as the
focus industries, commercial real estate, aviation, leisure, oil
and gas, as examples. And, while those sectors are not out of
the woods, we certainly see, and as we referred to yesterday, an
outlook that is cautiously optimistic on those sectors, but they
have represented the lion’s share of the IB provisions in the
year.
I think the other thing that one needs to remember, also, in IB,
so why would it happen in the early stage of a credit cycle in the
IB? One of the reasons for that is structured credit in our world.
Our portfolio is probably a little bit more responsive in that
sense but, interestingly, I think the loss history in structured
credit gives us some confidence of also looking to the future
around the portfolio and, if you like, the early part in the cycle at
which those CLPs are recognised in the investment bank.
Christy Hajiloizou 	Thank you.
Corrine Cunningham 	Good afternoon. Thanks very much for the call. A quick follow-
(Autonomous) 	up on the legacy and then maybe some questions about TLTRO.
On the legacy bonds, it sounds like you’re saying that they
would qualify as MREL, even if they don’t qualify as capital.
Have I understood that correctly, because they’re legacy, they
are issued by special purpose vehicles which would mean that
they are disqualified from capital purposes? So, I just wanted to
fully understand the implications of that.
Then, on TLTRO, you’ve gone from 34.0 to 37.5 and you
suggest that this could go higher still, so just if you’ve got an
idea of the scale, on how high that could go. Then, also, I wasn’t
fully following what you were saying in terms of what’s already
booked, what’s still to come, and the periods that relates to. So,
if you could give us, perhaps, maybe even just repeat, but a bit
of an explanation as to what’s been booked when on TLTRO
benefits. Thank you.
Dixit Joshi 	Corinne, sure. I’ll take those in turn. The first, on MREL, the
comment was much more to give clarity given the chatter
around infection risk, and we’re not subject to infection risk on
our stack and hence one of the factors behind also remaining

-- 10 of 15 --

11
comfortable with the surplus after absorbing the regulatory
downside. They would not quality for MREL but would naturally
qualify for LGF. Again, factoring in all of those considerations,
we would make call decisions at the appropriate time when
looking at the relative capital efficiency of those instruments.
On TLTRO, we ended that year at about a € 38 billion tap of the
facility and we’re likely to go up by, call it, € 3-4 billion through
the course of the year, starting with the March facility that we’d
be able to avail ourselves of. On the last question, if I understood
it correctly, Corinne, was it around revenue recognition and
catch-up?
Corinne Cunningham 	Yes, it was.
Dixit Joshi 	I’ll try and simplify it as best as I can but given we have six
quarters and we have three separate loan criteria to manage,
together with accruals and catch-ups, it’s a rather complicated
picture and so I’ll try to simplify it as best as I can and then, if
not, we can take that offline as well.
The first is that in the third quarter we had accrued for TLTRO
at a negative 17 basis points, which is a three-year average of
50 basis points in the first year, zero in the second and then zero
in the third. In the fourth quarter, we did reach accounting
certainty that we would meet the loan growth target, and this
was the loan growth target between March 19-21, and this
allowed us to accrue for TLTRO as a minus 50 basis points
instrument for the fourth quarter but also, then, required a
catch-up to 50 basis points for the third quarter. So, in total, we
accrued just over 40 million in the fourth quarter for this.
For 	the 	full 	year 	2020, 	we 	accrued 	in 	the 	region 	of
approximately € 85 million across all TLTRO instruments
including TLTRO-II from the first half of the year. Now, in 2021,
our effective rate will vary in each quarter based on similar
criteria. In the first quarter, as we reach accounting certainty on
the second growth target up until March 21, this will allow us to
accrue 100 basis points for the first quarter and a catch-up for
the second half of last year, as well. And so, all in, we expect to
book around € 125 million in the first quarter.
In the second quarter, we’ll accrue at 100 basis points, as a
continuing benefit for meeting that first or second growth
condition. Then, in the third quarter, we revert back to 50 basis
points because we will not, by then, have accounting certainty
as to the most recent growth condition, which gets measured at
the end of December ’21.
Then, finally, in the fourth quarter, as we achieve that certainty,

-- 11 of 15 --

12
we will then accrue 100 basis points for that quarter but also as
a catch-up for the third quarter. I hope that offers some clarity
around TLTRO and revenue recognition but, if not, happy to
take that offline.
Corrine Cunningham 	That’s much clearer. It sounds like there’s a lot of juggling going
on but, yes, I do understand it now. Thank you.
Lee Street 	Hello. Good afternoon. Thanks for taking my questions. I’ve got
(Citigroup) 	two, please. Just on the 5 billion of capital distribution to
shareholders, what is the timing of that? Is that the start of '22
or the end of '22? I'm just thinking around it. Obviously, it's
about 150 basis points of capital, as things stand at the
moment. I’m just trying to work out, should I be thinking that
the bank is going to be running around 14% Common Equity
Tier 1 at the start of '22, particularly your 12.5% minimum? Just
any thoughts around that just would be helpful.
Then, secondly, obviously, there is a big focus on the 8% return
on tangible equity target. Now, my working assumption is that
probably relatively limited execution on the costs, given that
swing is within your control. So, am I right in thinking the risks
of you not hitting that target, to the extent they exist, it’s all on
the revenues or are there any other areas or reasons that you
might call out? They would be my two questions. Thank you.
James von Moltke 	Sure. Thanks, Lee. It's James. So, quickly, on dividends, we
would essentially build into that full payout over time and we're
obviously mindful of the need to adhere to our CET1 ratio
targets and maintain a small buffer above them as being sort of
the constraint on the dividend or other distribution sort of
pattern. But, we do see a very clear path to the 5.0 billion return
over several years subject, of course, to profitability, regulatory
approval, and all of the things that go into that.
On the 8% ROTE, it's the whole package. Obviously, we work
very hard on everything within our control, costs notably. On the
risk 	side, 	obviously, 	we're 	continuing 	the 	risk 	discipline,
underwriting our credit book to manage to a CLP outcome that
would be in line with or perhaps even better than we laid out to
investors in December.
And, as you say, revenues is the hardest one to predict because
it depends on the market environment and a number of other
considerations but, again, in December, and yesterday we
discussed it as well, we feel that executing on the strategies, the
businesses have laid out and the wind down of the CRU puts us
on a good path towards the revenue number that feeds into our
8% model.
Lee Street 	Okay. That makes sense. And, just a quick follow-up on the first
one. I know your current target is at 12.5%. Could you envisage

-- 12 of 15 --

13
a scenario in the next two years where you might be lowering
that 12.5% target or do you think you’ll stick with that for some
time?
James von Moltke 	I think it's extremely unlikely that we would think differently
about that threshold over that timeframe.
Robert Smalley 	Hi. Thanks very much and thanks for doing the call. A couple of
(UBS) 	topics, first, on the loan loss provision, second, on issuance.
First, on the loan loss provision. We had a CFO in the States last
week say something along the lines of the impact of ongoing
stimulus could not only end up delaying peak losses but
deflating peak losses. Is this something that you would ascribe
to and, if so, how are you looking at that in terms of your
modelling? How does it work through to the experience with
Stage 1, Stage 2 and Stage 3, particularly given the release that
we've seen in Stage 1?
On issuance, just a couple of follow-ups. The 2021 plan, you've
already done Tier 2. Is your Pillar 2 optimised now for Tier 2 and
you'd more lean to AT1 for that issuance? And, in terms of
timing, given the RWA inflation that you talked about, as well as
potential increases in interest rates, do you want to pull some of
your funding forward into the first half of the year given what's
going on with the balance sheet and rates? Thank you.
James von Moltke 	Robert, it's James. I'll take the first. I would agree with that
statement. I think that both the fiscal and monetary support, in
my opinion will, for sure, have lessened the impact of this credit
cycle in terms of delinquencies, and, ultimately, the charges the
banks take in a number of ways.
One is it has supported demand in the economy. The second, it
has provided liquidity and also access to the capital markets for
corporates. It has supported the household sector as well and, I
think, just kept the economy moving over the bridge that was
the very sharp but also relatively short downturn. So, a very
unusual pattern relative to other cycles.
How it feeds into the staging? The staging is interesting. We are
looking at the forbearance impacts and other flags that have
arisen or ratings migration that hasn't taken place because of
that support. And I would say, Robert, it does not have that big
an 	impact, 	a 	surprisingly 	small 	impact 	on 	our 	IFRS 	9
provisioning.
Dixit Joshi 	Robert, I'll take the second two questions. On Tier 2 and AT1,
as you note, we've outlined 2-3 billion of potential issuance this
year, that already includes $ 1.25 billion of the Tier 2 issue that
we did in January. We retained flexibility through the course of
the year. We'll be looking at our legacy roll-off exposures,
looking 	at 	ensuring 	that 	we 	maintain 	our 	buffers 	above

-- 13 of 15 --

14
minimum regulatory requirements and also ensure that we
continue to make progress towards our leverage ratio target.
So, we have some flexibility but we wanted to give you
transparency that, as always, we have a placeholder for that
issuance and we've already commenced on some of that
issuance already.
In terms of pulling the issuance into H1, I think, this year, we’ve
kind of already pulled issuance into last year, if I may, and with
prefunding of around 5 billion in the fourth quarter of last year.
We tend to flex the issuance plan and timing around market
conditions, so left to be seen what the rest of the year looks like.
I would say, on balance, generally, yes, we do tend to do more
towards the earlier parts of the year but I would say, again, that's
dependent on market conditions.
Robert Smalley 	Thanks very much and thanks for doing the call.
James von Moltke 	As we mentioned yesterday, James Rivett will be moving to
another leadership role within Finance, and he'll be replaced or
succeeded as Head of IR by Ioana Patriniche, who's with us on
the call today. Ioana, as you know, is an 11-year veteran of our
Debt Capital Markets business and I hope you'll all see our
continued commitment to the credit investor dialogue in the
selection of Ioana for this role.
I hope you'll also all join us in congratulating James and
thanking him for the hard work he's done for DB over the last
several years as Head of our IR team and, before that, as Head
of Fixed Income Investor Relations. As you all know, he has an
impressive set of achievements in his various roles and has built
up a large following out there. So, please reach out to him and
for those of you who don't know Ioana, please get to know her.
Over to you, Philip.
Philip Teuchner 	Thank you. And, just to finish up, thank you all for joining us
today. You know where the IR team is, if you have further
questions, and we look forward to talking to you soon again.
Goodbye.
Disclaimer
This transcript contains forward-looking statements. Forward-looking statements are
statements that are not historical facts; they include statements about our beliefs and
expectations and the assumptions underlying them. These statements are based on plans,
estimates and projections as they are currently available to the management of Deutsche
Bank. Forward-looking statements therefore speak only as of the date they are made, and we
undertake no obligation to update publicly any of them in light of new information or future
events.

-- 14 of 15 --

15
By their very nature, forward-looking statements involve risks and uncertainties. A number of
important factors could therefore cause actual results to differ materially from those
contained in any forward-looking statement. Such factors include the conditions in the
financial markets in Germany, in Europe, in the United States and elsewhere from which we
derive a substantial portion of our revenues and in which we hold a substantial portion of our
assets, the development of asset prices and market volatility, potential defaults of borrowers
or trading counterparties, the implementation of our strategic initiatives, the reliability of our
risk management policies, procedures and methods, and other risks referenced in our filings
with the U.S. Securities and Exchange Commission. Such factors are described in detail in
our SEC Form 20-F of 20 March 2020 under the heading “Risk Factors.” Copies of this
document are readily available upon request or can be downloaded from www.db.com/ir.
This transcript also contains non-IFRS financial measures. For a reconciliation to directly
comparable figures reported under IFRS, to the extent such reconciliation is not provided in
this transcript, refer to the Q4 2020 Financial Data Supplement, which is available at
www.db.com/ir.
This transcript is provided solely for information purposes and shall not be construed as a
solicitation of an offer to buy or sell any securities or other financial instruments in any
jurisdiction. No investment decision relating to securities of or relating to Deutsche Bank AG
or its affiliates should be made on the basis of this document. Please refer to Deutsche Bank’s
annual and interim reports, ad hoc announcements under Article 17 of Regulation (EU) No.
596/2014 and filings with the U.S. Securities Exchange Commission (SEC) under Form 6-K.

-- 15 of 15 --